Wespac Advisors So Cal, LLC Amgen Inc Transaction History

Wespac Advisors So Cal, LLC

$390 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 02, 2022	SELL	$198.88 - $227.6 $954,027 - $1.09 Million	-4,797 Reduced 33.73%	9,425 $2.54 Million
Q3 2021 Oct 14, 2021	SELL	$212.27 - $248.7 $4.28 Million - $5.02 Million	-20,180 Reduced 58.66%	14,222 $3.01 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $1.71 Million - $1.89 Million	7,310 Added 26.98%	34,402 $8.39 Million
Q1 2021 Apr 30, 2021	BUY	$221.91 - $258.6 $443 - $517	2 Added 0.01%	27,092 $6.74 Million
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $359,190 - $427,732	1,660 Added 6.53%	27,090 $6.23 Million
Q3 2020 Oct 23, 2020	BUY	$234.65 - $260.95 $44,583 - $49,580	190 Added 0.75%	25,430 $6.02 Million
Q2 2020 Jul 17, 2020	BUY	$197.81 - $242.74 $402,543 - $493,975	2,035 Added 8.77%	25,240 $6.29 Million
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $403,843 - $535,607	-2,216 Reduced 8.72%	23,205 $5.45 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $190,156 - $244,416	-1,005 Reduced 3.8%	25,421 $6.13 Million
Q3 2019 Oct 17, 2019	BUY	$174.11 - $208.62 $27,335 - $32,753	157 Added 0.6%	26,426 $5.11 Million
Q2 2019 Jul 30, 2019	BUY	$166.7 - $195.41 $1.05 Million - $1.23 Million	6,305 Added 31.58%	26,269 $4.84 Million
Q1 2019 May 02, 2019	SELL	$180.87 - $203.88 $880,294 - $992,283	-4,867 Reduced 19.6%	19,964 $3.79 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $109,716 - $128,073	-615 Reduced 2.42%	24,831 $4.83 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $53,734 - $60,578	-290 Reduced 1.13%	25,446 $5.27 Million
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $867,611 - $974,514	5,225 Added 25.47%	25,736 $4.75 Million
Q1 2018 Apr 16, 2018	SELL	$169.43 - $198.0 $45,237 - $52,866	-267 Reduced 1.29%	20,511 $3.5 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $30,382 - $33,946	-180 Reduced 0.86%	20,778 $3.61 Million
Q3 2017 Nov 03, 2017	SELL	$167.29 - $191.0 $65,243 - $74,490	-390 Reduced 1.83%	20,958 $3.91 Million
Q2 2017 Aug 11, 2017	BUY	N/A	21,348	21,348 $3.68 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wespac Advisors So Cal, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wespac Advisors So Cal, LLC with notifications on news.

Account